Modification by SQ 14225 of blood pressure and adrenal catecholamine response to hemorrhage
- 1 April 1979
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 55 (2) , 203-206
- https://doi.org/10.1016/0014-2999(79)90393-5
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- SQ 14,225 (D-3-MERCAPTO-2-METHYLPROPANOYL-L-PROLINE), A NOVEL ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN I-CONVERTING ENZYME1978
- Effect of angiotensin-converting enzyme inhibitor (SQ 20881) on the plasma concentration of angiotensin I, angiotensin II, and arginine vasopressin in the dog during hemorrhagic shock.Circulation Research, 1977
- Renin-angiotensin mediation of adrenal catecholamine secretion induced by haemorrhageEuropean Journal of Pharmacology, 1977
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- Peptide antagonists of angiotensin-induced adrenal catecholamine releaseEuropean Journal of Pharmacology, 1977
- Adrenal Medullary Stimulation Induced by Angiotensin I, Angiotensin II, and AnaloguesCirculation Research, 1971
- The Nature of Irreversible ShockAnnals of Surgery, 1964